How many people in England and Wales are registered partially sighted or blind because of age-related macular degeneration?

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.9K citations · Full text

Medicine, Ophthalmology, Surgery +12

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

Daniel Martín, Maureen G. Maguire, Stuart L. Fine et al. · Ophthalmology · 2012 · 1.7K citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +12

Defining Cultural Competence: A Practical Framework for Addressing Racial/Ethnic Disparities in Health and Health Care

J. R. Betancourt · Public Health Reports · 2003 · 1.7K citations

Public Health, Health Education, Health Systems +17

Defining cultural competence: a practical framework for addressing racial/ethnic disparities in health and health care

Joseph R. Betancourt, Alexander R. Green, J. Emilio Carrillo et al. · Public Health Reports · 2003 · 1.4K citations

Public Health, Health Education, Health Systems +17

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

David M. Brown, Mark Michels, Peter K. Kaiser et al. · Ophthalmology · 2008 · 1.3K citations

Medicine, Ophthalmology, Surgery +15